Skip to main content
Fig. 1 | BMC Medical Informatics and Decision Making

Fig. 1

From: Validation of the effectiveness of a digital integrated healthcare platform utilizing an AI-based dietary management solution and a real-time continuous glucose monitoring system for diabetes management: a randomized controlled trial

Fig. 1

Study design. The study group includes 3 groups: Control group A (no intervention and conventional diabetes management), Experimental group B (applying the digital integrated healthcare platform by themselves, no monitoring and feedback from medical staff), and Experimental group C (applying the digital integrated healthcare platform with monitoring and feedback from medical staff and applying a CGMS). This parallel study will be conducted for 48 weeks

Back to article page